Clin Med Insights Case Rep. 2012;5:13-7. doi: 10.4137/CCRep.S8790. Epub 2012 Feb 16.
Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate.